
### [Orphanet:459537](http://www.orpha.net/ORDO/Orphanet_459537)
**Label:** Genetic complex vascular malformation with associated anomalies

**Subclasses:** [Orphanet:163634](http://www.orpha.net/ORDO/Orphanet_163634) (Maffucci syndrome), [Orphanet:2346](http://www.orpha.net/ORDO/Orphanet_2346) (Angioosteohypertrophic syndrome), [Orphanet:109](http://www.orpha.net/ORDO/Orphanet_109) (Bannayan-Riley-Ruvalcaba syndrome), [Orphanet:744](http://www.orpha.net/ORDO/Orphanet_744) (Proteus syndrome), [Orphanet:140944](http://www.orpha.net/ORDO/Orphanet_140944) (CLOVES syndrome), 

**Corr. equiv. classes:** [Orphanet:2346](http://www.orpha.net/ORDO/Orphanet_2346), [OMIM:612918](http://purl.obolibrary.org/obo/OMIM_612918), [OMIM:176920](http://purl.obolibrary.org/obo/OMIM_176920), [OMIM:149000](http://purl.obolibrary.org/obo/OMIM_149000), [OMIM:614569](http://purl.obolibrary.org/obo/OMIM_614569), [Orphanet:163634](http://www.orpha.net/ORDO/Orphanet_163634), [OMIM:153480](http://purl.obolibrary.org/obo/OMIM_153480), [Orphanet:109](http://www.orpha.net/ORDO/Orphanet_109), [OMIM:608355](http://purl.obolibrary.org/obo/OMIM_608355), [Orphanet:140944](http://www.orpha.net/ORDO/Orphanet_140944), [Orphanet:744](http://www.orpha.net/ORDO/Orphanet_744), 

**Class expressions from DL-Learner:**

- [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0001000](http://purl.obolibrary.org/obo/HP_0001000) (Abnormality of skin pigmentation) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100742](http://purl.obolibrary.org/obo/HP_0100742) (Vascular neoplasm) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) and [HP:0100742](http://purl.obolibrary.org/obo/HP_0100742) (Vascular neoplasm) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) and [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) and [HP:0100742](http://purl.obolibrary.org/obo/HP_0100742) (Vascular neoplasm) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) and [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) and [HP:0100742](http://purl.obolibrary.org/obo/HP_0100742) (Vascular neoplasm) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) and [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%
- [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.64%


